How This Works IGF-1 LR3 is a synthetic analog of human insulin-like growth factor-1 engineered with an N-terminal extension (13 amino acids) and a glutamic acid substitution at position 3, resulting in significantly reduced binding affinity to IGF binding proteins [1]
Grayson, MD, National Health Laboratory Service, Johannesburg, South Africa
The combination mimics the bodys GH cycles, maintaining hormonal balance
Collectively, these developments underscore the paramount contribution of nanotechnology to redox-based oncological diagnostics and therapeutics and promising avenues towards more efficient and personalized cancer therapy [111]
M.LiuC.LiP.ZhangC.ZhenJ.et al (2024b)
AOD-9604 provides an alternative that completely avoids the growth hormone axis